Post-exposure prophylaxis for COVID-19 is when medication is taken after you have been exposed to a person with COVID-19 to help build up protection against COVID-19, and therefore reduce the chance of developing severe COVID-19 or dying.
Post-exposure prophylaxis for COVID-19 is not a substitute for vaccination against COVID-19.
Prophylaxis after exposure to COVID-19 is only used for specific patients and in specific circumstances.
Post-exposure prophylaxis is used for patients who are:
- at high risk of progressing to be hospitalized or dying if they get COVID-19 and
- have not been fully vaccinated or their immune system is not expected to respond to a completed course of COVID19 vaccine and
- they have had close contact with someone who has COVID-19 or
- they live or work in an institutional setting where someone else has COVID-19 and they are at a high risk of exposure.
Drugs used to treat Post-Exposure Prophylaxis of COVID-19
Name | Drug Class |
---|---|
Regen-cov | Antiviral combinations |
Casirivimab and imdevimab | Antiviral combinations |
Bamlanivimab and etesevimab | Drugs |